July 6, 2020 / 11:22 AM / a month ago

BRIEF-Merck Announces New Analyses Showing Additional Safety, Efficacy Data For Investigational Islatravir In Combination With Doravirine In Adults With Hiv-1

July 6 (Reuters) - Merck & Co Inc:

* MERCK ANNOUNCES NEW ANALYSES SHOWING ADDITIONAL SAFETY AND EFFICACY DATA FOR INVESTIGATIONAL ISLATRAVIR IN COMBINATION WITH DORAVIRINE IN ADULTS WITH HIV-1 INFECTION

* MERCK & CO INC - ANALYSES ADD SUPPORT FOR FURTHER INVESTIGATION OF ISLATRAVIR IN COMBINATION WITH DORAVIRINE FOR CERTAIN PATIENTS

* MERCK - FIRST SUB-ANALYSIS FURTHER CHARACTERIZED TOLERABILITY, SAFETY PROFILE OF ISLATRAVIR IN COMBINATION WITH DORAVIRINE ACROSS 3 DOSES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below